Atlas Trials

BCG-induced Epigenetic Modifications in the NEXT Generation

Clinical trial NCT05766345 · UNKNOWN

Trial details

NCT number
NCT05766345
Sponsor
Radboud University Medical Center
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Trained ImmunityBCG VaccineEpigenetics
Start date
2023-10-02
Primary completion
2024-08-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.